KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,260,360 | +28.3% | 234,558 | +112.2% | 0.00% | +50.0% |
| Q2 2023 | $2,541,614 | -25.1% | 110,553 | -3.9% | 0.00% | -33.3% |
| Q1 2023 | $3,395,463 | +22.9% | 115,042 | +3.9% | 0.00% | +50.0% |
| Q4 2022 | $2,763,421 | -44.4% | 110,714 | -51.5% | 0.00% | -50.0% |
| Q3 2022 | $4,968,000 | +11.2% | 228,210 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $4,467,000 | -50.4% | 226,859 | +6.5% | 0.00% | -33.3% |
| Q1 2022 | $9,012,000 | -24.1% | 212,960 | +13.9% | 0.01% | -25.0% |
| Q4 2021 | $11,875,000 | +34.1% | 187,027 | +24.1% | 0.01% | +33.3% |
| Q3 2021 | $8,855,000 | +21.2% | 150,746 | +0.0% | 0.01% | +20.0% |
| Q2 2021 | $7,309,000 | +25.1% | 150,694 | +0.2% | 0.01% | +25.0% |
| Q1 2021 | $5,842,000 | -37.8% | 150,332 | -0.8% | 0.00% | -42.9% |
| Q4 2020 | $9,398,000 | +91.6% | 151,575 | -0.1% | 0.01% | +75.0% |
| Q3 2020 | $4,904,000 | – | 151,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |